Integration of CLM and PLM enables a streamlined approach to configuration management, leading to faster time to market and more satisfied customers COPENHAGEN, Denmark, Nov. 1, 2024 /PRNewswire/ ...

To get on the PCI-SIG integrators list, the PCI-SIG requires that a company’s entry passes several compliance tests. The E2969A PCI Express Protocol Test Card (PTC) provides the protocol ... the PCI ...

SCIEX, a global leader in life science analytical technologies, announces the localization of the SCIEX Triple Quad 6500+ system and the QTRAP 6500+ system in China. This announcement marks another ...

and gene therapy-enabling company offering precise navigation to the brain and spine, today congratulates its partner PTC Therapeutics on completion of its BLA submission to the U.S. Shareholders ...

In a report released today, Gena Wang from Barclays maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), with a price target of $45.00. The company’s shares closed yesterday at ...

Sami Corwin has given his Buy rating due to a combination of factors that favor PTC Therapeutics’ market position. The recent FDA approval of Kebilidi, a groundbreaking gene therapy for AADC ...

The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...

PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...

PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...

Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene therapy to ...

Industrial software maker PTC forecast first-quarter revenue below estimates on Wednesday, signaling continued weakness in ...

Vanguard Group Inc. raised its holdings in shares of PTC by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 13,740,919 shares of the technology company’s stock worth $2,596,209,000 after ...